Research Progress of DUB Enzyme in Hepatocellular Carcinoma

Research Progress of DUB Enzyme in Hepatocellular Carcinoma

According to GLOBOCAN 2021 cancer incidence and mortality statistics compiled by the International Agency for Research on Cancer, hepatocellular carcinoma (HCC) is the most common malignancy in the human liver and one of the leading causes of cancer death worldwide. Although there have been great ad...

Full description

Bibliographic Details
Main Authors: Jie Zhao, Jinhui Guo, Yanan Wang, Qiancheng Ma, Yu Shi, Feng Cheng, Qiliang Lu, Wen Fu, Guangxiong Ouyang, Ji Zhang, Qiuran Xu, Xiaoge Hu
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-06-01
Series:Frontiers in Oncology
Subjects:
ubiquitin
deubiquitinating enzymes
hepatocellular carcinoma
targeted
structure
inhibitors
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.920287/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2022.920287/full

Similar Items